Erin Stewart

Erin Stewart has an extensive background in clinical research and development. With experience in various roles at companies like ArteraAI, Pentavere, and Princess Margaret Cancer Centre, Erin has specialized in targeted therapy mechanisms and predictive biomarker discovery in lung cancer. Holding a Ph.D. in Medical Biophysics from the University of Toronto, Erin has also been involved in training coordination, project management, and scholarly liaison roles.